BioCentury
ARTICLE | Clinical News

ProOnc TumorSourceDx: Data

June 21, 2010 7:00 AM UTC

In a prospective study in 62 evaluable metastatic tissue samples from patients with CUP origin, miRview mets demonstrated 84% concordance with clinical presentation in predicting the cancer's tissue o...